Intravascular Lithotripsy Market to Reach US$ 1197.5 Mn by 2031, Driven by Rising CVD Cases

✅ Overview of the Global Intravascular Lithotripsy (IVL) Market

The global intravascular lithotripsy (IVL) market is poised for significant expansion, with its valuation expected to increase from US$ 489.1 million in 2024 to US$ 1,197.5 million by 2031. This robust growth is projected at a compound annual growth rate (CAGR) of 11.7% during the forecast period from 2024 to 2031. IVL is an innovative minimally invasive procedure that uses sonic pressure waves to fracture vascular calcifications, enabling better vessel compliance and facilitating effective stent placement. As cardiovascular diseases continue to rise globally, especially in aging populations, IVL technology is gaining widespread acceptance among clinicians and healthcare providers.

Key growth drivers fueling the IVL market include increasing prevalence of peripheral artery disease (PAD) and coronary artery disease (CAD), advancements in medical device technologies, and rising awareness about minimally invasive treatment options. The leading market segment by product is the peripheral intravascular lithotripsy devices, driven by the rising number of PAD cases worldwide. Geographically, North America holds the dominant position due to its well-established healthcare infrastructure, high adoption rate of advanced cardiovascular therapies, and strong presence of key market players investing heavily in R&D and marketing.

Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.persistencemarketresearch.com/samples/32139

✅ Key Highlights from the Global IVL Market Report

➤ The global IVL market is projected to grow at a CAGR of 11.7% from 2024 to 2031.
➤ Market value is expected to reach US$ 1,197.5 million by 2031 from US$ 489.1 million in 2024.
➤ Peripheral IVL devices segment leads the market due to increasing PAD prevalence.
➤ North America dominates the market owing to advanced healthcare infrastructure.
➤ Rising cardiovascular disease burden is a major factor driving IVL adoption.
➤ Technological innovations and growing clinical evidence are expanding market reach.

✅ What is Intravascular Lithotripsy (IVL) and How Does it Benefit Patients?

Intravascular lithotripsy is a cutting-edge treatment designed to address heavily calcified arterial plaques that complicate traditional angioplasty and stenting. It uses acoustic pressure waves to safely fracture calcium deposits within blood vessel walls without damaging the soft tissue. This facilitates the dilation of vessels and improves stent expansion, leading to better procedural success and reduced risk of complications such as restenosis or vessel rupture. Compared to conventional atherectomy or balloon angioplasty alone, IVL offers a less invasive, more targeted approach with shorter recovery times. This technology particularly benefits patients suffering from complex peripheral artery disease and coronary artery disease who have calcified lesions that are difficult to treat with standard methods.

✅ Market Segmentation of the Global IVL Industry

The IVL market is primarily segmented based on product type and end-user. By product, the market divides into peripheral intravascular lithotripsy devices and coronary intravascular lithotripsy devices. Peripheral devices hold the largest market share due to the higher incidence of peripheral artery disease globally and increasing demand for minimally invasive solutions. Coronary IVL devices are witnessing rapid adoption as they address calcified coronary lesions, which are a significant challenge in cardiovascular interventions.

From the end-user perspective, the market segments into hospitals, ambulatory surgical centers, and cardiac specialty clinics. Hospitals dominate due to their capacity to perform complex cardiovascular procedures and their role as primary treatment centers. Ambulatory surgical centers are growing in importance as they offer cost-effective, outpatient-based cardiovascular interventions. The increasing number of specialized cardiac clinics focusing on minimally invasive therapies further supports market growth.

✅ Regional Insights into the IVL Market

North America is the leading region in the IVL market due to a combination of factors such as advanced healthcare infrastructure, extensive research and development activities, and high awareness among physicians and patients about innovative cardiovascular treatments. The U.S. healthcare system's focus on early diagnosis and intervention for cardiovascular diseases has driven higher adoption rates of IVL devices.
Europe follows closely with growing healthcare expenditure and increasing prevalence of cardiovascular diseases. The presence of key manufacturers and reimbursement policies favoring innovative therapies also contribute to market growth. Asia Pacific is emerging as a promising region with increasing healthcare investments, rising patient awareness, and expanding healthcare infrastructure, particularly in countries like China, Japan, and India.

✅ Market Drivers

The rising global burden of cardiovascular diseases such as coronary artery disease and peripheral artery disease is a principal driver for the IVL market. As calcified lesions complicate traditional angioplasty outcomes, IVL provides a safer, more effective alternative. Additionally, technological advancements improving device efficacy and safety, alongside growing clinical evidence supporting IVL benefits, are encouraging widespread adoption. Increasing awareness among healthcare professionals about minimally invasive treatment options further propels market expansion.

✅ Market Restraints

Despite its advantages, the IVL market faces challenges including the high cost of devices and procedures, which may limit accessibility in low- and middle-income countries. Limited reimbursement policies in certain regions also hinder broader adoption. Furthermore, lack of extensive long-term clinical data compared to conventional therapies can make some healthcare providers hesitant. The market is also subject to stringent regulatory requirements which can delay product approvals and market entry.

✅ Market Opportunities

Significant opportunities exist in emerging economies where cardiovascular disease prevalence is rising rapidly, but access to advanced treatments remains limited. Expanding healthcare infrastructure and improving insurance coverage in these regions can open new markets. Additionally, ongoing research and innovation aimed at expanding IVL applications beyond vascular calcifications-such as in valvular heart diseases-could create new avenues for growth. Collaborations between device manufacturers and healthcare providers to improve education and training will further support market penetration.

✅ Reasons to Buy the Report

✔ Comprehensive analysis of market size, trends, and forecasts from 2024 to 2031
✔ In-depth segmentation by product type, end-user, and region for targeted insights
✔ Detailed competitive landscape with profiles of leading market players
✔ Identification of growth drivers, challenges, and future opportunities
✔ Strategic recommendations to capitalize on emerging market trends

✅ Company Insights and Recent Developments

✦ Shockwave Medical, Inc.
✦ Boston Scientific Corporation
✦ Medtronic plc
✦ Philips Healthcare
✦ B. Braun Melsungen AG
✦ Cardiovascular Systems, Inc.

■ Shockwave Medical received FDA approval for its coronary IVL system, enhancing market presence in the U.S.

■ Boston Scientific launched new peripheral IVL devices with improved design and enhanced patient safety features.

✅ Conclusion

The global intravascular lithotripsy market is on a strong growth trajectory fueled by the increasing prevalence of cardiovascular diseases and the growing need for minimally invasive treatment options. Technological innovations and rising clinical evidence continue to boost market adoption across various regions, especially North America and Europe. Despite certain challenges such as high costs and regulatory hurdles, emerging markets and expanding indications present significant opportunities. Stakeholders investing in R&D, market expansion, and strategic partnerships will be best positioned to capitalize on the promising future of the IVL market through 2031 and beyond.

✅About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

Contact Us:

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

This release was published on openPR.